/Companies

Atelerix Seed

4 known investors

Find your way into Atelerix Seed

193 people in our graph share verified history with the Atelerix Seed team — schools, employers, funds. One of them is your warm intro.

Atelerix develops hypothermic hydrogel encapsulation technology that stabilises and preserves fresh cells, tissues, and blood at room temperature, eliminating the need for cryopreservation and cold-chain logistics. Its plant-based, xeno-free kits (such as CytoStor, BeadReady, and STORganoid) serve research and clinical labs shipping live cell material, organoids, and 3D cell models.

Founders & leadership

SSSteve Swioklo
Steve SwiokloFounder · Chief Scientific OfficerSteve Swioklo holds a PhD from the University of Reading and conducted postdoctoral research at Newcastle University on hydrogel encapsulation of cells and tissues for room temperature preservation. He is co-founder and CSO of Atelerix, which develops cell preservation technologies for research and clinical applications.

Investors · 4

Frequently asked questions

What does Atelerix Seed do?
Atelerix develops hypothermic hydrogel encapsulation technology that stabilises and preserves fresh cells, tissues, and blood at room temperature, eliminating the need for cryopreservation and cold-chain logistics. Its plant-based, xeno-free kits (such as CytoStor, BeadReady, and STORganoid) serve research and clinical labs shipping live cell material, organoids, and 3D cell models.
Who founded Atelerix Seed?
Atelerix Seed was founded by Steve Swioklo.
Who are Atelerix Seed's investors?
Atelerix Seed's investors include Cambridge Angels group, Future Planet Capital, O2h Ventures, UK Innovation & Science Seed Fund.